文献速递其他结缔组织病自身炎症与 IgG4 相关病

黏膜皮肤起病白塞病患者重大器官受累风险:AIDA网络登记数据

Risk of major organ involvement in Behçet's patients with mucocutaneous onset: data from the AIDA Network Registry.
PubMed 文献 · Rheumatology (Oxford) · 2026-01-01

本研究基于国际自身炎症性疾病联盟(AIDA)网络白塞病登记库,纳入328例起病时为单纯黏膜皮肤表现的患者,其中82例(25%)在整个随访期间出现重大器官受累(MOI)。小口腔阿弗他溃疡且无大口腔阿弗他溃疡者MOI风险降低(OR 0.41),而大口腔阿弗他溃疡合并小口腔阿弗他溃疡、生殖器阿弗他溃疡或假性毛囊炎者及有白塞病家族史者MOI风险升高。

要点

  • 起病时单纯黏膜皮肤表现的白塞病患者中,25%(82/328)随访期间出现重大器官受累。
  • 仅有小口腔阿弗他溃疡且无大口腔阿弗他溃疡与MOI风险降低相关(OR 0.41)。
  • 大口腔阿弗他溃疡合并小口腔阿弗他溃疡、生殖器阿弗他溃疡或假性毛囊炎及家族史与MOI风险升高相关。

核心结论

  • 起病时为黏膜皮肤型白塞病患者中,白塞病家族史阳性以及大口腔阿弗他溃疡合并小口腔阿弗他溃疡、生殖器阿弗他溃疡或假性毛囊炎与重大器官受累的发生相关。

研究设计与样本

  • 数据来自国际自身炎症性疾病联盟(AIDA)网络白塞病登记库;纳入328例起病时为单纯黏膜皮肤表现的白塞病患者。

主要发现

  • 328例起病时为单纯黏膜皮肤表现的患者中,82例(25%)在整个随访期间出现重大器官受累(MOI)。
  • 有小口腔阿弗他溃疡且无大口腔阿弗他溃疡者MOI风险降低,OR 0.41(95%CI 0.22-0.79,P = 0.008)。
  • 同时有大口腔阿弗他溃疡和小口腔阿弗他溃疡者MOI风险升高,OR 12.76(95%CI 1.44-113,P = 0.02)。
  • MOI与大口腔阿弗他溃疡合并生殖器阿弗他溃疡(OR 2.49,95%CI 1.1-5.6,P = 0.03)、合并假性毛囊炎(OR 2.9,95%CI 1.15-7.4,P = 0.02)及合并两者(OR 3.73,95%CI 1.22-11.4,P = 0.02)相关。
  • 白塞病家族史阳性与MOI相关,OR 2.85(95%CI 1.08-7.58,P = 0.03)。

关键数值与推荐

  • MOI风险降低:有小口腔阿弗他溃疡且无大口腔阿弗他溃疡,OR 0.41(95%CI 0.22-0.79,P = 0.008)。
  • MOI风险升高:同时有大口腔阿弗他溃疡和小口腔阿弗他溃疡,OR 12.76(95%CI 1.44-113,P = 0.02)。
  • MOI风险升高:大口腔阿弗他溃疡合并生殖器阿弗他溃疡,OR 2.49(95%CI 1.1-5.6,P = 0.03)。
  • MOI风险升高:大口腔阿弗他溃疡合并假性毛囊炎,OR 2.9(95%CI 1.15-7.4,P = 0.02)。
  • MOI风险升高:大口腔阿弗他溃疡合并生殖器阿弗他溃疡及假性毛囊炎,OR 3.73(95%CI 1.22-11.4,P = 0.02);家族史阳性OR 2.85(95%CI 1.08-7.58,P = 0.03)。

临床怎么用

  • 对起病时为黏膜皮肤型白塞病患者,可依据口腔阿弗他溃疡类型、是否合并生殖器阿弗他溃疡或假性毛囊炎及家族史识别MOI风险较高者。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The progression of Behçet's disease (BD) from a mucocutaneous-limited form to major organ involvement (MOI) represents a significant challenge. This study aims to identify patients without MOI at BD onset who are at increased risk of developing MOI in later stages. METHODS: Patients' data were drawn from the International AutoInflammatory Disease Alliance (AIDA) Network registry dedicated to BD. RESULTS: A total of 328 patients with exclusively mucocutaneous manifestations at BD onset were enrolled. Of these, 82 patients (25%) developed MOI over the entire follow-up period. Patients with minor oral aphthosis and no major oral aphthosis exhibited a reduced risk of developing MOI, with an odds ratio (OR) of 0.41 [95% confidence interval (95%CI): 0.22-0.79, P = 0.008]. Conversely, patients with both major and minor oral aphthosis had a significantly higher risk of developing MOI, with an OR of 12.76 (95%CI: 1.44-113, P = 0.02). Moreover, the development of MOI was associated with major oral aphthosis plus genital aphthosis (OR: 2.49, 95%CI: 1.1-5.6, P = 0.03), major oral aphthosis plus pseudofolliculitis (OR: 2.9, 95%CI: 1.15-7.4, P = 0.02) and major oral aphthosis plus both genital aphthosis and pseudofolliculitis (OR: 3.73, 95%CI: 1.22-11.4, P = 0.02). A positive family history for BD was associated with MOI (OR: 2.85, 95%CI: 1.08-7.58, P = 0.03). CONCLUSION: A positive family history and the presence of major oral aphthosis combined with minor oral aphthosis, genital aphthosis or pseudofolliculitis are associated with MOI development in patients with mucocutaneous BD at onset.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Vitale A, Gavioli F, Caggiano V, et al. Risk of major organ involvement in Behçet's patients with mucocutaneous onset: data from the AIDA Network Registry. Rheumatology (Oxford). 2026. PMID: 41259668. doi:10.1093/rheumatology/keaf613

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。